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Abstract
Background: Infective endocarditis (IE) is a life-threatening disease. Despite advancements in diag-
nostic methods, the initial clinical presentation of IE remains a valuable asset. Therefore, the impact 
of clinical presentation on outcomes and its association with microorganisms and IE localization were 
assessed herein. 
Methods: This retrospective study included 183 patients (age 68.9 ± 14.2 years old, 68.9% men) 
with definite IE at two tertiary care hospitals in Belgium. Demographic data, medical history, clinical 
presentation, blood cultures, imaging data and outcomes were recorded.
Results: In-hospital mortality rate was 22.4%. Sixty (32.8%) patients developed embolism, 42 (23%) 
shock, and 103 (56.3%) underwent surgery during hospitalization. Shock at admission predicted 
embolism during hospitalization (odds ratio [OR] 2.631, 95% confidence interval [CI] 1.119–6.184,  
p = 0.027). A new cardiac murmur at admission predicted cardiac surgery (OR 1.949, 95% CI 1.007–
–3.774, p = 0.048). Methicillin resistant Staphylococcus aureus predicted in-hospital mortality and 
shock (p = 0.005, OR 6.945, 95% CI 1.774–27.192 and p = 0.015, OR 4.691, 95% CI 1.348–16.322, 
respectively). Mitral valve and aortic valve IE predicted in-hospital death (p = 0.039, OR 2.258, 95% 
CI 1.043–4.888) and embolism (p = 0.017, OR 2.328, 95% CI 1.163–4.659), respectively.  
Conclusions: In this retrospective study, shock at admission independently predicted embolism dur-
ing hospitalization in IE patients. Moreover, a new cardiac murmur at admission predicted the need 
for cardiac surgery. This emphasizes the importance of a comprehensive initial clinical evaluation in 
combination with imaging and microbiological data, in order to identify high-risk IE patients early. 
(Cardiol J)
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Introduction
Despite improvements in medical and surgi-
cal therapy, infective endocarditis (IE) remains 
a deadly disease, with a vast array of potential 
complications [1, 2]. While imaging, particularly 
echocardiography, is the main diagnostic tool in 
patients with suspected IE [2], the initial clinical 
presentation remains a valuable asset. However, 
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non-specific, influenced by predisposing conditions, 
causative microorganisms and IE localization [3, 4]. 
This could cause a diagnostic delay with increased 
complications and mortality [5]. Therefore, the 
present study sought to assess the impact of initial 
clinical presentation on outcome of IE patients 
during hospitalization and its association with 
microorganisms and IE localization.  
Methods
Patients with definite IE diagnosed by the 
modified Duke criteria [2] were retrospectively 
included in a comprehensive database from 2015 
to 2018. This study was conducted at two tertiary 
care hospitals in Belgium: UZ Brussel and AZ Maria 
Middelares Gent. 
Demographic data, medical history, clinical 
presentation at admission, blood cultures, imaging 
data and outcomes were recorded. Transthoracic 
and transoesophageal echocardiography had been 
performed in all patients. 
Admission data was defined as data from the 
first 24 hours of hospitalization. 
Outcomes during hospitalization (more than 24 h 
after admission) included: in-hospital mortality, 
embolic events (cerebro-vascular and non-cerebro-
vascular, diagnosed with imaging modalities), shock 
(cardiogenic or septic) and cardiac surgery.
Cardiac surgery was performed following cur-
rent guideline recommendations [2].
Statistical analysis
Continuous variables were expressed as mean 
± standard deviation. Categorical variables were 
expressed as percentages. Comparison of continu-
ous variables was done with the Student t-test or 
Mann–Whithney U test. Comparison of binomial 
variables was done with a c2 or the Fisher exact 
test. In order to evaluate potential predictors of 
outcomes, a multivariate logistic regression mod-
eling was used. Variables with a p-value < 0.10 
in the univariate analysis along with variables of 
known clinical importance were included in the 
multivariate analysis. Statistical significance was 
considered for a p-value < 0.05. Statistical analyses 
were conducted using IBM SPSS Statistics (Ver-
sion 26.0.0, SPSS, Chicago, IL, USA).
Ethical approval
The study was approved by the local Ethics 
Committee of both hospitals and was carried out in 
accordance with the ethical principles for medical 
research involving human subjects established by 
the Helsinki Declaration, protecting the privacy 
of all participants, as well as the confidentiality of 
their personal information. 
Results
Baseline population characteristics 
One hundred eighty-three patients with defi-
nite IE (age 69 ± 14.2 years old, 68.9% males) were 
included. 51% of patients had previous valvular 
heart disease. Baseline characteristics are shown 
in Table 1. 
At admission, clinical presentation consisted 
primarily of fever, general non-wellbeing and 
dyspnea. 61 (33.3%) patients presented with a new 
cardiac murmur at admission. 28 (15.3%) patients 
presented with shock and 33 (18%) patients had 
embolic events at admission. Initial clinical pres-
entation can be found in Table 2. 
Microbiological data are presented in Table 3. 
An average of 3.5 ± 2.3 antibiotic therapies was 
used per patient.
Echocardiography at admission showed na-
tive aortic valve IE in 56 (30.6%) and aortic valve 
prosthesis IE in 37 (20.2%) patients, among the 
51 (27.8) patients with aortic valve prosthesis. 
Table 1. Baseline and demographic characteristics.
Total  
(n = 183)
Age [year] 69.0 ±14.2
Male 68.9%
Medical history
Previous endocarditis 11 (6.0%)
Heart failure 25 (13.7%)
Coronary artery disease 43 (23.5%)
Atrial fibrillation 41 (23.3%)
Cardiac device 25 (13.7%)
Arterial hypertension 86 (47.0%)
Diabetes mellitus 16 (8.7%)
Previous stroke 24 (13.1%)
Chronic kidney disease 40 (21.9%)
Cancer 23 (12.6%)
Valve disease 93 (50.8%)
History of cardiac surgery/ 
/invasive interventions
86 (47.0%)
History of non-cardiac invasive  




Acetylsalicylic acid 62 (33.9%)
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Native mitral valve IE was found in 70 (38.2%) 
patients and prosthetic mitral valve IE in 10 (5.4%) 
patients, among them 14 (7.6%) patients had 
a mitral valve prosthesis. 23 (12.5%) patients had 
multivalvular endocarditis. 
Predictors of outcome
Univariate analysis is shown in Supplemental 
material (Suppl. Table 1). Multivariate analysis 
can be found in Table 4.
In-hospital mortality. In-hospital mortality 
rate was 22.4% (41 patients). Clinical presentation 
at admission was not predictive for in-hospital 
mortality. However, by multivariate analysis, both 
Methicillin resistant Staphylococcus aureus (MRSA) 
and mitral valve IE were independent predictors for 
in-hospital mortality (p = 0.005, odds ratio [OR] 
6.945, 95% confidence interval [CI] 1.774–27.192 
and p = 0.039, OR 2.258, 95% CI 1.043–4.888, 
respectively).
Embolic events. Sixty (32.8%) patients 
developed embolic events during hospitalization. 
Shock at admission independently predicted embo-
lism (OR 2.631, 95% CI 1.119–6.184, p = 0.027). 
When adjusted by IE localization, aortic valve 
IE was also an independent predictor of embolic 
events (OR 2.328, 95% CI 1.163–4.659, p = 0.017).
Shock. Forty-two (23%) patients developed 
cardiogenic shock (16 patients) or septic shock 
(26 patients) during hospitalization. Initial clinical 
presentation was not predictive for shock. When 




General non-wellbeing 56 (30.6%)
Dyspnea 38 (20.8%)
Cough 14 (7.7%)
Acute pulmonary edema 4 (2.2%)
Chest pain 6 (3.3%)





Cardiogenic shock 10 (5.4%)
Septic shock 18 (9.8%)
Congestive heart failure 15 (8.2%)
New cardiac murmur 61 (33.3%)
Osler noduli 4 (2.2%)
Janeway lesions 7 (3.8%)
Roth spots 2 (1.1%)
Splinter hemorrhages 5 (2.7%)
Conjunctival hemorrhages 2 (1.1%)
Table 3. Microbiological data. 
Total  
(n = 183)
Staphylococcus aureus 45 (24.6%)
Methi – S Staphylococcus aureus 34 (18.6%)
Methi – R Staphylococcus aureus 11 (6%)
Coagulase negative Staphylococcus 27 (14.8%)
Methi – S Staphylococcus CN 13 (7.1%)
Methi – R Staphylococcus CN 14 (7.7%)
Streptococcus viridans 50 (27.3%)
Enterococcus 21 (11.5%)
Streptococcus gallolyticus 21 (11.5%)
Other 17 (9.3%)
Coxiela burnetii IgG  
anti phase I > 1:800
1 (0.5%)
Blood culture negative 5 (2.7%) 
Methi – S — methicillin sensitive; Methi – R — methicillin resistant; 
CN — coagulaso-negative
Table 4. Multivariate independent predictors of outcomes. 
Outcomes Predictor Odds ratio 95% CI P 
In-hospital mortality Age 1.035 1.004–1.067 0.028
MRSA 6.945 1.774–27.192 0.005
Mitral valve IE 2.258 1.043–4.888 0.039
Embolic events Shock at admission 2.631 1.119–6.184 0.027
Aortic valve IE 2.328 1.163–4.659 0.017
Shock MRSA 4.691 1.348–16.322 0.015
Surgery New cardiac murmur 1.949 1.007–3.774 0.048
MRSA — Methicillin resistant Staphylococcus aureus; IE — infective endocarditis; CI — confidence interval
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adjusted for microorganisms, MRSA IE indepen-
dently predicted shock during hospitalization (OR 
4.691, 95% CI 1.348–16.322, p = 0.015). 
Cardiac surgery. Surgery was performed in 
103 (56.3%) patients. The presence of a new car-
diac murmur at admission independently predicted 
the need for cardiac surgery (OR 1.949, 95% CI 
1.007–3.774, p = 0.048). 
Discussion
This retrospective study showed that: 
1) A new cardiac murmur at admission independent-
ly predicted cardiac surgery; 2) Shock at admission 
was an independent predictor of embolic events 
during hospitalization; 3) MRSA infection was an 
independent predictor of in-hospital mortality and 
shock during hospitalization; 4) Mitral valve IE was 
an independent predictor of in-hospital mortality; 
5) Aortic valve IE independently predicted embolic 
events during hospitalization. 
In-hospital mortality
In-hospital mortality (22.4%) was comparable 
to previous studies, but remains unacceptably 
high despite optimal medical and surgical man-
agement [1, 6–8]. In this study, the initial clinical 
presentation was not predictive for in-hospital 
mortality, while previous studies found conges-
tive heart failure and embolic events at admission 
to be predictive of in-hospital death [7–11]. Other 
recent studies found in-hospital development of 
heart failure and septic shock to be predictive of 
in-hospital mortality [12]. However, in this current 
analysis only the initial presentation at admission 
was considered.
When adjusting for causative microorganisms, 
MRSA was predictive of in-hospital mortality. Pre-
viously, S. aureus has been identified as a predictor 
of in-hospital mortality, but no distinction between 
MRSA and Methicillin-susceptible Staphylococcus 
aureus (MSSA) was made [5, 7, 8, 11]. Nonethe-
less, another previous, prospective study showed 
a statistically non-significant increased mortality 
in MRSA vs. MSSA IE [13].
Moreover, mitral valve IE was associated 
with increased in-hospital mortality, as previously 
described by Murdoch et al. [5]. Patient character-
istics may be responsible for the worse outcome 
in mitral valve IE [14]. However, in this study, no 
association was found between mitral valve IE 
and characteristics such as causative microorgan-
isms, age or other complications. Furthermore, 
other studies did not find a significant difference in 
mortality between aortic and mitral valve IE [15].
In the ESC-EORP European endocarditis reg-
istry, in hospital mortality was associated with the 
Charlson index, creatinine > 2 mg/dL, congestive 
heart failure, cerebral complication, perivalvu-
lar abscess, vegetation length and unperformed 
cardiac surgery (when indicated) by multivariate 
analysis [1]. No such associations were found in 
this retrospective series.
Embolic events 
32.8% of IE patients developed an embolic 
event during hospitalization, which is higher than 
in the ESC-EORP European endocarditis registry 
(20.5%) [1] and the ICE cohort (23%) [5]. An initial 
presentation with shock (septic or cardiogenic) 
at admission was an independent predictor of 
embolic events. In shock, systemic inflammation, 
circulatory changes and hypercoagulopathy may 
be underlying contributors to the development 
of embolic events [16–18]. Shock-induced atrial 
fibrillation could also predispose to embolization 
[19]. Previous data have shown that septic shock 
increases the risk of stroke [18, 20]. In the Embolic 
Risk French calculator proposed by Hubert et al. 
[21], shock has not been analyzed as a possible 
predictor of embolic risk. Future research might 
be helpful to determine whether shock at admis-
sion could be incorporated into an adapted embolic 
risk calculator.
Additionally, aortic valve IE independently 
predicted embolic events during hospitalization, as 
also found in the ESC-EORP European endocardi-
tis registry [1]. In contrast, Hubert et al. [21] and 
Thuny et al. [22] found embolic risk to be indepen-
dent of valve localization. Vilacosta et al. [23] found 
embolization to be associated with mitral valve IE 
when vegetation size exceeds 10 mm. However, 
in this series there was no significant difference 
in vegetation size between aortic and mitral valve 
IE (13.4 ± 6.7 mm vs. 13.5 ± 5.8 mm, p = 0.949). 
Another study showed that embolism was more 
frequently seen in mitral prosthetic than aortic 
prosthetic valve thrombosis [24]. In this series, 
aortic valve prosthesis IE (20.2%) was more com-
mon than mitral valve prosthesis IE (5.4%).
In the ESC-EORP European endocarditis 
registry, in-hospital embolic events were also 
associated with staphylococcal infection [1]. 
A microbiological association could not be confirmed 
in this study. Thus, it remains uncertain why aortic 




23% of IE patients developed shock (septic or 
cardiogenic) as a complication during hospitaliza-
tion, compared to 16% in the ESC-EORP European 
endocarditis registry [1]. Other studies have shown 
a lower incidence for isolated septic shock [8, 25]. 
In this study, initial clinical presentation was not 
predictive of shock. In contrast, MRSA bacteriemia 
was an independent predictor of shock during 
hospitalization. Similarly, Olmos et al. [25] showed 
S. aureus to be and independent predictor of septic 
shock, without distinguishing between MRSA and 
MSSA. Shock has previously been identified as 
a common complication of MRSA bacteremia [26]. 
Severe shock has been shown to be more frequent 
in S. aureus IE compared to other pathogens [27]. 
Cardiac surgery 
Cardiac surgery was performed in 56% of IE 
patients, which is comparable to previously re-
ported operative rates [1, 5, 11, 28]. In this study, 
a new cardiac murmur at admission was predictive 
of surgery. The presence of a new cardiac murmur 
in IE patients may reflect important turbulence 
due to valvular damage. This finding confirms that 
a thorough physical examination at admission remains 
invaluable despite the readily availability of imag-
ing modalities such as echocardiography in current 
clinical practice. Detection of a new clinical murmur 
could help in the identification of patients eligible 
for early surgery, in dialogue with the endocarditis 
“Heart Team” [2]. Therefore, advanced investiga-
tions should be considered as a supplement, but 
not a replacement of a careful clinical examination.
Limitations of the study
This is a retrospective study with a limited num-
ber of patients. Therefore, larger prospective clinical 
studies are warranted to confirm the present findings.
Conclusions
In this retrospective study, shock at admis-
sion independently predicted embolism during 
hospitalization in IE patients. Moreover, a new 
cardiac murmur at admission predicted the need 
for cardiac surgery. These findings emphasize 
the importance of a comprehensive initial clinical 
evaluation, in spite of the availability of medical 
imaging and microbiological information, for an 
early identification of IE patients at high-risk of 
complications or a need for surgery. 
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